to provide timely, optimized dosing recommendations of re-purposed and new medications to combat COVID-19.

Key facts

Disease
COVID-19
start year
2020
Known Financial Commitments (USD)
$435
Funder
Gates Foundation
Principal Investigator
N/A
Research Location
France
Lead Research Institution
Institut National de la Sant√© et de la Recherche M√©dicale
Research Priority Alignment
N/A

N/A

Last Updated:42 minutes ago

Authors
Néant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferré V, Hartard C, Plantier JC, Thibault V, Marlet J, Montes B, Bouiller K, Lescure FX, Timsit JF, Faure E, Poissy J, Chidiac C, Raffi F, Kimmoun A, Etienne M, Richard JC, Tattevin P, Garot D, Le Moing V, Bachelet D, Tardivon C, Duval X, Yazdanpanah Y, Mentré F, Laouénan C, Visseaux B, Guedj J, French COVID Cohort Investigators and French Cohort Study groups.
Publish Year
2021
Journal
Proceedings of the National Academy of Sciences of the United States of America
DOI
10.1073/pnas.2017962118